Heterotopic ossification happens when bone grows outside of its normal location and into the surrounding soft tissues of your body. When this happens, the pieces of bone that develop are called ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...
Drug trial shows reduced abnormal bone formation in those with fibrodysplasia ossificans progressiva
A multisite, international phase 2 trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation ...
The Food and Drug Administration approved Sohonos, Ipsen Pharmaceuticals’ ultra-rare bone disease drug, Wednesday evening. The drug capsules are approved with an indication as a retinoid for reducing ...
Proposed model for Regulation of BMP Activity by DDR2. After binding collagen, DDR2 alone or together with collagen-binding β1 integrins stabilizes YAP/TAZ nuclear accumulation. This is accomplished ...
- Initial NHHO study targets patients with traumatic SCI who have high rates of HO, which causes abnormal bone growth in soft tissues - BRISBANE, Calif.--(BUSINESS WIRE)--āshibio, a privately held, ...
Ipsen SA’s drug for a debilitating disorder that slowly immobilizes patients within a cage of abnormal bone growth will cost roughly $624,000 a year in the US, after the French drugmaker won clearance ...
Multiple myeloma is an uncommon cancer affecting plasma cells in the bone marrow. Tumors in the bones and other organs can cause the cells to grow out of control. A complication of this cancer is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback